Company Legal Name
Latest Valuation
Founded Year
Headquarter
Hippocratic AI develops specialized artificial intelligence agents designed to assist healthcare providers with non-diagnostic, patient-facing clinical tasks. Founded in 2023 and headquartered in Palo Alto, the company addresses critical staffing shortages in healthcare by automating routine interactions such as patient intake, appointment scheduling, and care coordination. The startup has achieved rapid recognition in the healthcare AI sector, securing a $1.64 billion valuation within its first year of operation. Hippocratic AI's platform enables medical professionals to focus on complex diagnostic and treatment decisions while AI agents handle time-consuming administrative and patient communication responsibilities, positioning the company at the forefront of healthcare workflow optimization.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





